Latest AI and machine learning research in skin cancer for healthcare professionals.
Breast cancer is highly heterogeneous,and different molecular subtypes exhibit significant variation...
Colorectal cancer (CRC) is a health burden due to its high mortality rate, recurrence rate, and drug...
INTRODUCTION: Prostate cancer is well known to be androgen-dependent, with growth directly relying o...
INTRODUCTION: The combination of phototherapy (PTT/PDT) and immunotherapy holds promise for cancer t...
BACKGROUND: Minimally invasive biomarkers predicting immunotherapy response in head and neck squamou...
The classification of immunophenotypes in muscle-invasive bladder cancer (MIBC) is critical for pred...
Immunotherapy has transformed cancer treatment but remains ineffective in many solid tumors, largely...
PURPOSE: Predictive biomarkers of response to immune checkpoint inhibitors (ICI) remain poorly defin...
Nanomedicine offers powerful opportunities to overcome the pharmacokinetic and microenvironmental li...
Skin cancer is one of the most prevalent and potentially life-threatening cancers globally, making i...
There are large variations in how individual patients respond to allergen immunotherapy (AIT) agains...
BACKGROUND: Osteosarcoma, an aggressive bone malignancy with limited response to immunotherapy, rema...
The cGAS-STING pathway is a central regulator of innate immunity and exhibits a complex dual functio...
PURPOSE: This study aimed to reveal the mechanism and prognostic significance of migrasome-related g...
Endometrial cancer incidence and mortality are rising globally, disproportionately affecting health ...
BACKGROUND: The intratumoral heterogeneity and immunosuppressive microenvironment of hepatocellular ...
In medical image analysis, skin lesion diagnosis remains a complicated task. Skin lesions are a prev...
Rectal cancer remains a global health burden, with immunotherapy emerging as a transformative treatm...
Micropeptides are emerging as a previously hidden layer of the human proteome, redefining the long-s...
BACKGROUND: Melanoma outcomes differ across countries, income settings, and skin tones, reflecting n...
Predicting the clinical efficacy of Natural Killer (NK) cell immunotherapies remains challenging due...